Commercializing a breakthrough advance in inflammation science. MORE
Antibe Therapeutics is a publicly traded biotechnology company exploiting groundbreaking advances in inflammation science.
Antibe Therapeutics Collaborates with Dalriada Drug Discovery to Accelerate Pipeline Expansion
Antibe Therapeutics Announces Close of Amalgamation Transaction to Unify Intellectual Property Ownership
Antibe Therapeutics to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
Antibe Therapeutics Receives FDA Clearance of IND Application for Otenaproxesul for Osteoarthritis